These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38452161)

  • 1. Adverse Events Reported in Trials Assessing Manual Therapy to the Extremities: A Systematic Review.
    Ferguson J; Fritsch A; Rhon DI; Young JL
    J Integr Complement Med; 2024 Jun; 30(6):507-517. PubMed ID: 38452161
    [No Abstract]   [Full Text] [Related]  

  • 2. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of Complications in Rhinoplasty Randomized Controlled Trials: An Analysis Using the CONSORT Extension for Harms Checklist.
    Hemmerich C; Corcoran A; Johnson AL; Wilson A; Orris O; Arellanes R; Vassar M
    Otolaryngol Head Neck Surg; 2024 Jul; 171(1):81-89. PubMed ID: 38613190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review.
    Williams MR; McKeown A; Pressman Z; Hunsinger M; Lee K; Coplan P; Gilron I; Katz NP; McDermott MP; Raja SN; Rappaport BA; Rowbotham MC; Turk DC; Dworkin RH; Smith SM
    J Pain; 2016 Nov; 17(11):1137-1149. PubMed ID: 27522950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review.
    Mohiuddin MM; Mizubuti G; Haroutounian S; Smith S; Campbell F; Park R; Gilron I
    JMIR Res Protoc; 2019 Jan; 8(1):e11637. PubMed ID: 30688655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review.
    Moskowitz A; Andersen LW; Holmberg MJ; Grossestreuer AV; Berg KM; Granfeldt A
    Crit Care; 2020 Jul; 24(1):398. PubMed ID: 32641148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliciting adverse effects data from participants in clinical trials.
    Allen EN; Chandler CI; Mandimika N; Leisegang C; Barnes K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):MR000039. PubMed ID: 29372930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harms-related data are poorly reported among randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guideline recommendations for rotator cuff injuries.
    Anderson JM; Howard C; Hardin J; Phelps CR; Hanson C; Anderson RM; Vassar M; Checketts JX
    J Shoulder Elbow Surg; 2022 Dec; 31(12):e620-e627. PubMed ID: 35961499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harms reporting in randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guidelines for glenohumeral osteoarthritis.
    Chauhan A; Kotlier JL; Thompson AA; Mayfield CK; Abu-Zahra M; Hwang NM; Bolia IK; Petrigliano FA; Liu JN
    J Shoulder Elbow Surg; 2024 Mar; 33(3):e109-e115. PubMed ID: 37898417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review.
    Hunsinger M; Smith SM; Rothstein D; McKeown A; Parkhurst M; Hertz S; Katz NP; Lin AH; McDermott MP; Rappaport BA; Turk DC; Dworkin RH
    Pain; 2014 Nov; 155(11):2253-62. PubMed ID: 25123543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review.
    Péron J; Maillet D; Gan HK; Chen EX; You B
    J Clin Oncol; 2013 Nov; 31(31):3957-63. PubMed ID: 24062406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder.
    Meister R; von Wolff A; Mohr H; Nestoriuc Y; Härter M; Hölzel L; Kriston L
    J Clin Epidemiol; 2016 Mar; 71():97-108. PubMed ID: 26482955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain: A Systematic Review.
    Mohiuddin MM; Mizubuti GB; Haroutounian S; Smith SM; Rice ASC; Campbell F; Park R; Gilron I
    Clin J Pain; 2020 Apr; 36(4):302-319. PubMed ID: 31977375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
    Junqueira DR; Zorzela L; Golder S; Loke Y; Gagnier JJ; Julious SA; Li T; Mayo-Wilson E; Pham B; Phillips R; Santaguida P; Scherer RW; Gøtzsche PC; Moher D; Ioannidis JPA; Vohra S;
    J Clin Epidemiol; 2023 Jun; 158():149-165. PubMed ID: 37100738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations.
    Smith SM; Wang AT; Katz NP; McDermott MP; Burke LB; Coplan P; Gilron I; Hertz SH; Lin AH; Rappaport BA; Rowbotham MC; Sampaio C; Sweeney M; Turk DC; Dworkin RH
    Pain; 2013 Jul; 154(7):997-1008. PubMed ID: 23602344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reporting of adverse events following spinal manipulation in randomized clinical trials-a systematic review.
    Gorrell LM; Engel RM; Brown B; Lystad RP
    Spine J; 2016 Sep; 16(9):1143-51. PubMed ID: 27241208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.
    Kumar S; Mohammad H; Vora H; Kar K
    J Evid Based Dent Pract; 2018 Jun; 18(2):130-141.e22. PubMed ID: 29747793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria.
    Carmichael K; Nolan SJ; Weston J; Tudur Smith C; Marson AG
    Epilepsy Res; 2015 Aug; 114():106-13. PubMed ID: 26088893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.